Teveten (eprosartan) is a small molecule pharmaceutical. Eprosartan was first approved as Teveten on 1997-12-22. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. The pharmaceutical is active against type-1 angiotensin II receptor.
|Indication||diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction|
|Drug Class||Angiotensin II receptor antagonists|